Antitumor agent, kit, and method for treating cancer

Details for Australian Patent Application No. 2008356312 (hide)

Owner TAIHO PHARMACEUTICAL CO., LTD. SHIZUOKA PREFECTURE

Inventors Park, Sung Hwa

Agent Griffith Hack

Pub. Number AU-A-2008356312

PCT Pub. Number WO2009/139085

Priority 2008-124504 12.05.08 JP

Filing date 29 August 2008

Wipo publication date 19 November 2009

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2009/139085 Priority application(s): WO2009/139085

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008356409-Quinuclidine derivatives as muscarinic M3 receptor antagonists

2008356303-Lipoprotein lipase-activating compositions comprising benzene derivates